The FDA’s decision was based largely on clinical data from the first 21 patients to receive the device.

Cardiogenic shock patients who underwent right heart catheterization had lower mortality and stroke rates during their index admission. An improvement was also seen in that group's 30-day readmission rate. 

After years of delays, the initiative's usefulness has "diminished significantly," imaging leaders from several noted institutions wrote in Health Affairs. 

The portable solution demonstrated its value in a new study funded by the American Heart Association.

Should CABG and PCI patients be concerned about potential long-term cognitive issues? The current evidence is unclear. 

A team of FDA researchers led the study, testing the magnets found in various iPhone 12 and Apple Watch 6 models. 

Researchers tracked data from the UK Biobank study, presenting their findings at ESC Congress 2021.  

The new analysis, published in the New England Journal of Medicine, included data from more than 2.1 million patients.

The study, part of ESC Congress 2021, examined each patient's eating habits, coronary flow reserve, arterial stiffness and more. 

Clinicians, the USPSTF wrote, should work to help any patients diagnosed with prediabetes seek out preventive interventions.